1. Home
  2. ALMS vs NL Comparison

ALMS vs NL Comparison

Compare ALMS & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • NL
  • Stock Information
  • Founded
  • ALMS 2021
  • NL 1891
  • Country
  • ALMS United States
  • NL United States
  • Employees
  • ALMS N/A
  • NL N/A
  • Industry
  • ALMS
  • NL Major Chemicals
  • Sector
  • ALMS
  • NL Industrials
  • Exchange
  • ALMS NYSE
  • NL Nasdaq
  • Market Cap
  • ALMS 402.6M
  • NL 362.9M
  • IPO Year
  • ALMS 2024
  • NL N/A
  • Fundamental
  • Price
  • ALMS $3.29
  • NL $7.14
  • Analyst Decision
  • ALMS Strong Buy
  • NL Sell
  • Analyst Count
  • ALMS 7
  • NL 1
  • Target Price
  • ALMS $26.83
  • NL $6.00
  • AVG Volume (30 Days)
  • ALMS 1.1M
  • NL 29.2K
  • Earning Date
  • ALMS 05-14-2025
  • NL 05-07-2025
  • Dividend Yield
  • ALMS N/A
  • NL 5.05%
  • EPS Growth
  • ALMS N/A
  • NL 441.25
  • EPS
  • ALMS N/A
  • NL 1.25
  • Revenue
  • ALMS $17,389,000.00
  • NL $148,242,000.00
  • Revenue This Year
  • ALMS N/A
  • NL $15.75
  • Revenue Next Year
  • ALMS N/A
  • NL $2.44
  • P/E Ratio
  • ALMS N/A
  • NL $5.72
  • Revenue Growth
  • ALMS N/A
  • NL N/A
  • 52 Week Low
  • ALMS $3.18
  • NL $5.21
  • 52 Week High
  • ALMS $13.53
  • NL $9.42
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • NL 36.06
  • Support Level
  • ALMS N/A
  • NL $7.15
  • Resistance Level
  • ALMS N/A
  • NL $7.59
  • Average True Range (ATR)
  • ALMS 0.00
  • NL 0.43
  • MACD
  • ALMS 0.00
  • NL -0.11
  • Stochastic Oscillator
  • ALMS 0.00
  • NL 2.59

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About NL NL Industries Inc.

NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

Share on Social Networks: